CD274 and kidney cancer: A study of the positive rates of PD-L1, TMB, and MSI in 155 kidney cancer samples found that the positive rates of TMB and MSI were only 1/155 each, while the positive rate of PD-L1 was higher (46/155), and 108/155 tumors were negative for all three (Vanderwalde et al., 2018).